Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hodgkin's disease in children.

M P Sullivan1

  • 1Department of Pediatrics, M.D. Anderson Hospital and Tumor Institute, Houston, Texas.

Hematology/Oncology Clinics of North America
|December 1, 1987
PubMed
Summary

Effective Hodgkin's disease treatment combines radiotherapy and chemotherapy, achieving 90% cure rates. For children, chemotherapy alone or reduced-dose combined therapy is preferred, minimizing long-term risks from splenectomy and high-dose radiotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of the physical environment to support everyday activities for people with dementia: A systematic review.

Dementia (London, England)·2016
Same author

A meta-review of stress, coping and interventions in dementia and dementia caregiving.

BMC geriatrics·2016
Same author

Nanotechnology: current concepts in orthopaedic surgery and future directions.

The bone & joint journal·2014
Same author

Megaesophagus in a line of transgenic rats: a model of achalasia.

Veterinary pathology·2014
Same author

Heterotopic ossification after central nervous system trauma: A current review.

Bone & joint research·2013
Same author

Progress in understanding of inhibitory purinergic neuromuscular transmission in the gut.

Neurogastroenterology and motility·2013

Area of Science:

  • Oncology
  • Pediatric Oncology
  • Radiation Oncology

Background:

  • Hodgkin's disease management has advanced, with combined modality treatments achieving high cure rates.
  • The role of staging laparotomy is increasingly questioned due to improved imaging technologies.
  • Concerns exist regarding long-term effects of splenectomy and high-dose radiotherapy in pediatric patients.

Purpose of the Study:

  • To review current management strategies for Hodgkin's disease.
  • To evaluate the necessity of staging laparotomy in combination therapy.
  • To discuss optimal treatment approaches for pediatric Hodgkin's disease, considering long-term sequelae.

Main Methods:

  • Review of existing literature on Hodgkin's disease treatment regimens.
  • Analysis of the impact of advanced imaging (CT, MRI, ultrasound) on staging accuracy.
  • Evaluation of chemotherapy and radiotherapy dose-response and toxicity data.

Main Results:

  • Combined modality therapy allows for reduced doses of radiotherapy and chemotherapy.
  • Improved imaging reduces the need for staging laparotomy, especially in children.
  • Chemotherapy alone or reduced-dose combined therapy is effective and safer for pediatric patients.
  • Careful drug selection is crucial to minimize long-term toxicities like infertility and secondary malignancies.

Conclusions:

  • Combined modality treatment is standard for most Hodgkin's disease presentations.
  • Staging laparotomy's role is diminishing with advancements in non-invasive staging.
  • Pediatric treatment should prioritize minimizing long-term risks, favoring chemotherapy-based approaches.
  • Optimizing chemotherapy regimens and drug selection is vital for cure and long-term patient well-being.

Related Experiment Videos